Drug Approval Package

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

-

Drug Approval Package

Veramyst (fluticasone furoate)
Company: GlaxoSmithKline
NDA: 022051
Approval Date: 4/27/2007

Approval Letter(s) (PDF)
Printed Labeling (PDF)
Medical Review(s)
- Part 1 (PDF)
- Part 2 (PDF)
- Part 3 (PDF)
Chemistry Review(s) (PDF)
Environmental Assessment (PDF)
Pharmacology Review(s) (PDF)
Statistical Review(s) (PDF)
Microbiology Review(s) (PDF)
Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
Proprietary Name Review(s) (PDF)
Administrative Document(s) and Correspondence (PDF)
- Part 1 (PDF)
- Part 2 (PDF)

Date created: November 3, 2008

Back to Top Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-

-

-

-

-